EUVIMEDEUVIMED entdecken
Open Access

Germline testing for veterans with advanced prostate cancer: concerns about service-connected benefits

Daniel H Kwon iD, Maren T Scheuner, Marissa McPhaul, Eliza Hearst, Saffanat Sumra iD, Carling Ursem, Evan Walker iD, Sunny Wang iD, Franklin W Huang iD, Rahul R Aggarwal, Jeff Belkora iD

JNCI Cancer Spectrum · 2024

DOI: 10.1093/jncics/pkae079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI Cancer Spectrum, 2024. Verfasst von Daniel H Kwon und 10 weiteren Autor:innen. Beteiligte Einrichtung: Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Veterans, Genetic Testing, Genetic Predisposition to Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: US Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To better understand veterans’ decisions about germline testing, we conducted a single-site, qualitative study of 32 veterans with advanced prostate cancer. Seven days after oncologist-patient discussions about germline testing, we conducted semistructured interviews with patients to explore their decision-making process using an interview guide. Four of 14 veterans with service-connected disability benefits for prostate cancer declined germline testing for fear of losing benefits because their livelihood depended on these benefits. All 18 veterans without service-connected benefits agreed to testing. Veterans declining germline testing based on this concern can lead to suboptimal cancer care because targeted treatments that could improve their outcomes may go unrecognized. Our findings contributed to new language in the Veterans Benefits Administration Compensation and Pension Manual clarifying that genetic testing showing hereditary predisposition is insufficient to deny service-connected benefits for conditions presumed to be caused by military exposures. Clinicians should communicate this protection when counseling veterans about genetic testing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsVeteransGenetic TestingGenetic Predisposition to DiseaseQualitative ResearchHumansMaleMiddle AgedAgedUnited StatesDecision MakingGenetic CounselingVeterans Disability Claims

Autor:innen und Institutionen

  • Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.
  • Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Department of Medicine, San Francisco VA Health Care System, San Francisco, CA, USA.
  • Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.
  • Department of Surgery, University of California San Francisco, San Francisco, CA, USA.
  • Institute for Health Policy Studies, University of California San Francisco, San Francisco, CA, USA.

ORCID-Profile: Daniel H Kwon, Saffanat Sumra, Evan Walker, Sunny Wang, Franklin W Huang, Jeff Belkora

Förderung

  • US Department of Defense

Zitieren

APA

Kwon, D. H., Scheuner, M. T., McPhaul, M., Hearst, E., Sumra, S., Ursem, C., Walker, E., Wang, S., Huang, F. W., Aggarwal, R. R., & Belkora, J. (2024). Germline testing for veterans with advanced prostate cancer: concerns about service-connected benefits. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkae079

Vancouver

Kwon DH, Scheuner MT, McPhaul M, Hearst E, Sumra S, Ursem C, et al. Germline testing for veterans with advanced prostate cancer: concerns about service-connected benefits. JNCI Cancer Spectrum. 2024. doi:10.1093/jncics/pkae079

BibTeX
@article{Kwon2024,
  author = {Kwon, Daniel H and Scheuner, Maren T and McPhaul, Marissa and Hearst, Eliza and Sumra, Saffanat and Ursem, Carling and Walker, Evan and Wang, Sunny and Huang, Franklin W and Aggarwal, Rahul R and Belkora, Jeff},
  title = {Germline testing for veterans with advanced prostate cancer: concerns about service-connected benefits},
  journal = {JNCI Cancer Spectrum},
  year = {2024},
  doi = {10.1093/jncics/pkae079}
}
Kostenlos starten →